 |
 May 30-June 1, 2007,
Stamford Plaza Hotel Brisbane
Queensland, Australia |
 |
 |
 |
 |
 |
 |
Past DSB Programs |
| 2004 >> 2003 >> 2002 >> | 2006 >> 2005 >> |
 |
| DSB 2004 MEETING ~ Sydney, Australia |
| Wednesday 5th May |
| 12 Midday |
Exhibition set-up,
Coffee and Registration |
Cockle Bay Rooms |
|
| 1:15 pm - 1:30 pm |
Welcome: Keith Stanley |
| 1:30 pm - 3:15pm |
Session 1: Personalised medicine and nanotechnology
Chair: Rob Sutherland, Garvan Institute of Medical Research
Sponsored by: ADVANCED LABS |
| 1:30 pm - 2:15pm |
Edison Liu, Genome Institute, Singapore |
Gene profiling in breast cancer |
| 2:15 pm - 2:45 pm |
Matt Trau, The University of Queensland |
Drug & Gene Nano-Balls: Applications of Nanotechnology in Genomics, Proteomics, Drug Discovery and Diagnostics |
| 2:45 pm - 3:15 pm |
Rob Sutherland, Garvan Institute of Medical Research |
Identification of new prognostic markers and therapeutic targets for prostate cancer through genome wide transcript profiling |
|
| 3:15 pm - 3:45 pm |
Afternoon tea |
Cockle Bay Rooms |
|
| 3:45 pm - 5:15 pm |
Session 2: Genomics and functional genomics
Chair: Bryce Vissel, Garvan Institute of Medical Research
Sponsored by: MILLENNIUM SCIENCE |
| 3:45 pm - 4:15 pm |
David Martin, Victor Chang Cardiac Research Institute, Sydney |
Germline epimutations in human disease |
| 4:15 pm - 4:45 pm |
Peter Little, UNSW |
Genetic variation and the control of transcription |
4:45 pm - 5:15 pm |
Dick Cotton, St Vincent's Hospital Melbourne |
The problem of collecting all mutations causing inherited disease |
| 5:15pm - 5:45 pm |
Gene Tanimoto, Affymetrix/Millennium Science |
The power of the Probe Set: What’s in store for your next Affymetrix Microarray experiment? |
|
|
Optional Dinners |
Cockle Bay Wharf/Darling Harbour |
 |
| Thursday 6th May |
| 9:00 am -10:00 am |
Session 3: Bioinformatics
Chair: Keith Stanley, Centre for Immunology |
| 9:00 am - 9:30 am |
Marc Wilkins, Proteome Systems |
Bioinformatics for proteomics: algorithms, integration and visualisation |
| 9:30 am - 10:00 am |
Mark Ragan, IMB, Queensland |
High-throughput bioinformatics: automating the search for lateral gene transfer |
|
| 10:00 am - 10:30 am |
Coffee |
Cockle Bay Rooms |
|
| 10:30 am - 12:45 pm |
Session 4: Proteomics
Chair: Mark Baker, Australian Proteome Analysis Facility
Sponsored by: BECKMAN COULTER |
| 10:30 am - 11:15 am |
Julia Wulfkuhle, Clinical Proteomics Program, NIH, Bethesda, Maryland |
Protein microarrays: Molecular profiling technologies for diagnosis and monitoring of cancer |
| 11:15 am - 11:45 am |
Tony Weiss, Sydney University |
Proteomics of linked tropoelastin multimers |
| 11:45 am - 12:15 pm |
Stuart Cordwell and Melanie White, APAF |
TBA |
12:15pm -12:45pm |
Duncan Veal, FLUOROtechnics, Sydney |
Fluorescent Tools in Proteomics |
|
| 12:45 pm - 1:45 pm |
Lunch |
Cockle Bay Rooms |
|
| 1:45 pm - 2:15 pm |
Trade Secrets™ |
Cockle Bay Rooms |
|
| 2:15 pm - 3:15 pm |
Session 5: From Research to Retail
Chair: Iain Scott, Australian Life Scientist
Sponsored by: AUSTRALIAN LIFE SCIENTIST |
| 2:15 pm - 2:45 pm |
Stephen Livesey, NSCC, Melbourne |
From concept to profitability- One perspective |
| 2:45 pm - 3:15 pm |
Greg Collier, Deakin University |
AGT Biosciences from Genomics to Therapeutics |
|
| 3:15 pm - 3:45 pm |
Tea |
Cockle Bay Rooms |
|
| 3:45 pm - 5:30 pm |
Session 6: Natural products and biodiversity
Chair: Ron Quinn, Griffiths University
Sponsored by: ASTRA ZENECA |
| 3:45 pm - 4:30 pm |
Tony Buss, Merlion Pharma, Singapore |
A New Model for Utilising Chemical Diversity from Natural Products |
| 4:30 pm - 5:00 pm |
Paul Alewood, University of Queensland |
Venoms to drugs |
| 5:00 pm - 5:30 pm |
Rohan Davis, Griffith University, QLD |
Bioactive Secondary Metabolites from Endophytic Fungi |
|
| 5:30 pm - 6:30 pm |
Mixer |
Cockle Bay Rooms |
|
| 6:45 pm - 10:00 pm |
Conference Dinner |
King Street Wharf |
| Friday 7th May |
| 9:00 am -11:00 am |
Session 7: Cancer genomics and proteomics
Chair: Erik (Rik) Thompson, St Vincents Institute of Medical Research, Melbourne |
| 9:00 am - 9:30 am |
Jane Armes, University of Melbourne |
Genotype-Phenotype correlations in breast
cancer |
| 9:30 am - 10:00 am |
Susan Clark, Sydney Cancer Institute |
DNA methylation and gene silencing in cancer |
| 10:00 am - 10:30 am |
Mark Waltham, St. Vincent's Institute of Medical Research, Melbourne |
Gene expression profiling cancer models of epithelial-to-mesenchymal transition |
| 10:30am - 11:00 am |
Rob Baxter, Kolling Institute, Sydney |
SELDI-TOF in cell biology and diagnostics |
|
| 11:00 am - 11:30 am |
Coffee |
Cockle Bay Rooms |
|
| 11:30 pm - 1:15pm |
Session 8: Protecting and commercialising innovation
Chair: Vivien Santer, Griffith Hack
Sponsored by: GRIFFITH HACK |
| 11:30 am - 12:15 pm |
Gábor Lamm, EMBLEM, Heidelberg |
Turning Ideas into Products: The Innovation Process at EMBL |
| 12:15 pm - 12:45 pm |
Richard Jefferson, CAMBIA |
The BIOS initiative - open source biology |
| 12:45 pm - 1:15 pm |
Vivien Santer, Griffith Hack |
Biotechnology Patents- Changes on the Horizon? |
|
| 1:15 pm - 2:15 pm |
Lunch |
Cockle Bay Rooms |
|
| 2:15 pm - 3:45 pm |
Session 9: Brain development and diseases
Chair: Peter Schofield, Garvan Institute of Medical Research
Sponsored by: |
| 2:15 pm - 2:45pm |
Peter Schofield, Garvan Institute of Medical Research |
Genetic polymorphism (Val66Met) in brain derived growth factor gene associated with deficits in episodic and working memory in humans |
| 2:45 pm - 3:15 pm |
Brian Dean, Mental Health Research Institute of Victoria |
Combining genomics and proteomics to understand the pathologies of psychiatric illnesses. |
| 3:15 pm - 3:45 pm |
Marko Premzl, RSBS, ANU |
The prion protein gene: detecting regulatory signals using tammar wallaby sequence |
|
| 3:45 pm - 4:15 pm |
Afternoon tea |
Cockle Bay Rooms |
|
|
|
| DSB 2003 MEETING~ Sydney, Australia |
|
INTERNATIONAL KEYNOTE SPEAKERS |
|
Professor Alan Colman
famous for his work in the production of transgenic animals and then the cloning of "Dolly" and now director of research programs with ES-Cell International in their Singapore Labs. He was elected a member of EMBO in 1998 and is scientific advisor to a large number of pre-eminent scientific organisations. |
 |
Dr Andrew Fraser
group leader in the prestigious Sanger Institute in Cambridge. His recent work uses genome wide RNAi approaches to determine gene function (Nature Jan 16, 2003). These studies have lead to new concepts in the interplay of signalling pathways in development. |
|
| Thursday 15th May |
| 7:45 am - 8:30 am |
Coffee and Registration |
| 8:30 am - 8:45 am |
Welcome: |
| 8:45 am - 10:15 am |
Genetic origins of disease
Chair: Peter Schofield, Garvan
Sponsored by: |
| 8:45 am - 9:15 am |
Steven Petrou (Bionomics ) |
Bionomics IonXTM drug discovery program: Opening a new window on ion channel function and drug discovery |
| 9:15 am - 9:45 am |
Nick Martin (QIMR) |
Genetic Epidemiology |
| 9:45 am - 10:15 am |
Simon Easteal (ANU) |
Genome Diversity and Disease |
| |
|
|
| 10:15 am - 10:45 am |
Coffee |
| 10:45 am - 12:30 pm |
Functional Genomics
Chair:
Sponsored by: |
| 10:45 am - 11:30 am |
Functional Genomics Keynote Address:
Andrew Fraser (Sanger Institute, Cambridge) Genome-wide functional genomics using RNAi |
| 11:30 am - 12:00 pm |
Geoff Symonds (Johnson & Johnson) |
Ribozymes |
| 12:00 pm - 12:30 pm |
Chris Wraight (Antisense Therapeutics) |
Antisense strategies |
|
|
|
| 12:30 pm - 1:30 pm |
Lunch |
| 1:30 pm - 2:00 pm |
Trade Secrets™ |
| 2:00 pm - 3:30 pm |
Innovation - Commercialisation
Chair: Karen Dado, PWC
Sponsored by: PricewaterhouseCoopers |
| 2:00 pm - 2:30 pm |
Craig Lawn (PricewaterhouseCoopers) |
Commercialising innovation |
| 2:30 pm - 3:00 pm |
Matt McNamara (SciCapital) |
Funding early stage projects |
| 3:00 pm - 3:30 pm |
Jonathan Izant (Garvan) |
Innovative Business Strategies for Discovery Research |
| |
|
|
| 3:30 pm - 4:00 pm |
Afternoon tea |
| 4:00 pm - 6:00 pm |
Proteomics
Chair: Mark Baker, APAF
Sponsored by: Amersham Biosciences |
| 4: 00 pm - 4:30 pm |
Robin Anders (La Trobe, CRC Vaccine Technology) |
From protein structure to vaccine |
| 4:30 pm - 5:00 pm |
Ian Smith (Baker Institute) |
Beyond the Spot: High Throughput Automated Proteomics |
| 5:00 pm - 5:30 pm |
Michael Foley (La Trobe) |
Phage display in diagnostics and vaccine development |
| 5:30 pm - 6:00 pm |
Jenny Harry (Proteome Systems) |
Using proteomics to drive discovery of new biomarkers, diagnostics and drug targets |
| |
|
|
| 6:00 pm |
Posters & Wine |
| 7:00 pm - 10:00 pm |
Conference Dinner |
|
|
| Friday 16th May |
| 8:30 am -10:30 am |
Advances in Genomics
Chair: Charles Mackay, Garvan
Sponsored by: Millennium Science |
| 8:30 am - 9:00 am |
Deon Venter (MCRI) |
Arrays and expression profiling |
| 9:00 am - 9:30 am |
Rohan Teasdale (IMB) |
Reverse Transfection |
| 9:30 am - 10:00 am |
Hamish Scott (WEHI) |
A molecular atlas of developing, adult and diseased brains defined using serial analysis of gene expression (SAGE) |
| 10:00 am - 10:15 am |
Stephen Wilcox (AGRF) |
Using DNA Microarrays for SNP detection |
| 10:15 am - 10:30 am |
Robert Henke (Millennium) |
NewArray-based tools for whole genome analysis |
| |
|
|
| 10:30 am - 11:00 am |
Coffee |
| 11:00 am - 1:00 pm |
SNPs in gene discovery and personalised medicine
Chair:
Sponsored by |
| 11:00 am - 11:30 am |
Jeff Thornton (Sequenom) |
Genome-wide SNP Association for Complex Disease Gene Discovery and Molecular Diagnosis |
| 11:30 am - 12:00 pm |
Jeremy Jowett (International Diabetes Institute) |
Discovery and Validation of Disease Related Genes using Differential Expression and SNP Genotyping |
| 12:00 pm - 12:30 pm |
Karl Poetter (Genera Biosystems) |
Sequence Identification Flow Test for genetic diagnosis |
| 12:30 pm - 1:00 pm |
Garry King (UNSW) |
Some new tools for personalized medicine - electrotides, proofreading SBE, BVML and captamers |
|
|
|
| 1:00 pm - 2:00 pm |
Lunch |
| |
|
|
| 2:00 pm - 4:15 pm |
Stem cell biotechnology
Chair:
Sponsored by: |
| 2:00 pm - 2:45 pm |
Stem cell biotechnology Keynote address:
Alan Colman (ESCell International) Prospects of stem cell therapy in diabetes |
| 2:45 pm - 3:15 pm |
Helen Cooper (University of Queensland) |
Gene expression in adult neural stem cell development |
| 3:15 pm - 3:45 pm |
Rosanne Taylor (University of Sydney) |
Neural repair with stem cells |
| 3:45 pm - 4:15 pm |
Alan Mackay-Sim (Griffith University) |
Therapeutic use of olfactory stem cells |
| |
|
|
| 4:15 pm - 4:45 pm |
Close & afternoon tea |
|
|
DSB 2002 MEETING ~ Sydney, Australia |
| Thursday 16th May |
| 7:45 am - 8:30 am |
Coffee and Registration |
| 8:30 am - 8:45 am |
Welcome: |
| 8:45 am - 10:50 am |
Fast-Tracking Research with DNA arrays
This session will introduce the latest developments in the use of DNA microarrays
Chair: Keith Stanley |
| 8:45 am - 9:30 am |
Tom Freeman
(MRC Human Genome Mapping Programme,
Cambridge) |
Prospects for microarray analysis in an academic setting |
| 9:30 am - 10:00 am |
Charles Mackay
Garvan Medical Research (Institute, Sydney) |
Affymetrix gene profiling for inflammatory diseases, and integration with Celera database, SNP detection, and disease association |
| 10:00 am - 10:30 am |
Andrew Holloway (PMCI, Melbourne) |
Gene arrays and cancer classification |
| 10:30 am - 10:50 am |
Martin McCall (Centre for Immunology) |
Complete human genome screen for novel anti-inflammatory targets |
|
|
|
| 10:50 am - 11:30 am |
Coffee |
| 11:30 am - 12:30 pm |
Stem Cells, development, and biotechnology
Human stem cells offer an unparallelled resource for human therapy, but at the same time an ethical dilemma. This session will discuss the opportunities and issues arising from the therapeutic use of stem cells.
Chair: Keith Stanley |
| 11:30 pm - 12:00 pm |
Peter Rathjen (University of Adelaide) |
Stem cells and the future of medicine |
| 12:00 pm - 12:30 pm |
Hirofumi Doi (Celestar Lexico-Sciences) |
A slant on stem cells, learned from gene expression of mouse early embryos |
|
|
|
| 12:30 pm - 1:45 pm |
Lunch |
| 1:45 pm - 2:15 pm |
Trade Secrets™ |
|
|
|
| 2:15 pm - 3:45 pm |
Commercialising Biodiscovery
What must be sacrificed by a scientist to commercialise an idea? How many obstacles are there? These and other commercialisation questions will be addressed in this session.
Chair: David Black (DeLoitte TT) |
| 2:15 pm - 2:45 pm |
David Adamthwaite
(Baldwin Shelston Waters) |
Protect or publish? |
| 2:45 pm - 3:15 pm |
Lee Ridge (Photonics CRC) |
Linking Research to Finance |
| 3:15 pm - 3:45 pm |
Mark Bradley (ATP-Innovations) |
The long and winding road: biotechnology commercialisation in Australia |
|
|
|
| 3:45 pm - 4:15 pm |
Afternoon tea |
| 4:15 pm - 5:15 pm |
Evolution of a Biotech Company
Case studies from a scientists perspective of what is involved in the formation of a biotech company.
Chair: Peter French |
| 4:15 pm - 4:45 pm |
Peter Colman (Biota) |
Early history of Biota |
| 4:45 pm - 5:15 pm |
Peter Gage (Biotron) |
Commercialisation of university research: from academia to the ASX |
|
|
|
| 5:15 pm - 6:30 pm |
Exhibition , Posters & Wine |
| 7:00 pm - 9:30 pm |
Conference Dinner |
| Friday 17th May |
| 8:45 am -10:15 am |
Biotechnology platforms of the 21st Century
A sample of the offering from biotechnology companies in the near future.
Chair: John Barlow |
| 8:45 am - 9:15 am |
Richard Harrison (Applera) |
Faster, stronger, higher; the technologies driving the genomic revolution. |
| 9:15 am - 9:45 am |
Bruce Cornell (AMBRI) |
Biosensors |
| 9:45 am - 10:15 am |
Andrew Gooley (Proteome systems) |
ProteomIQ - an automated and integrated proteomic platform |
|
|
|
| 10:15 am - 10:45 am |
Coffee and Trade Display |
| 10:45 am - 12:20 pm |
Proteomics
Protein arrays and antibody techniques are close to commercial products. What will these be used for and which techniques will work the best?
Chair: Ivan Rajkovic
Sponsored by Baldwin Shelston Waters |
| 10:45 am - 11:30 am |
Dolores Cahill (MPI, Berlin) |
Protein arrays: Generation and applications |
| 11:30 am - 12:00 pm |
Richard Simpson (Ludwig Institute, Melbourne) |
Protein analysis beyond 2D gels |
| 12:00 pm - 12:20 pm |
John Whitelock (CSIRO) |
Proteomic analysis of proteoglycans |
|
|
|
| 12:20 pm - 1:30 pm |
Lunch |
| 1:30 pm - 2:50 pm |
Arrays in novel applications
Chair: Charles MacKay |
| 1:30 pm - 2:00 pm |
Robyn Ward (St Vincent's Hospital, Sydney) |
New cancer therapies, the cup runneth over |
| 2:00 pm - 2:30 pm |
Richard Christopherson (University of Sydney) |
Immunophenotyping of leukemias using a cluster of differentiation antibody microarray |
| 2:30 pm - 2:50 pm |
Els N Meeusen (University of Melbourne) |
Novel sheep asthma model for drug discovery and formulation |
|
|
|
| 2:50 pm - 3:30 pm |
Afternoon Tea |
| 3:30 pm - 5:00 pm |
Global Biotechnology Opportunities
Biotechnology succeeds on its appeal to the global market. Perspectives of the opportunities for Australia and experiences in the problems of technology transfer.
Chair: Keith Stanley |
| 3:30 pm - 4:00 pm |
Ken-ichi Arai (Japan) |
Pacific Rim Biotechnology |
| 4:00 pm - 4:30 pm |
Eugen Takagi (Xcelerator) |
Japanese bio venture today and strong needs of overseas collaboration |
| 4:30 pm - 5:00 pm |
Gabor Lamm (Germany) |
Innovation to Commercialisation: A European Perspective |
|
|
|
| 5:00 pm - 6:00 pm |
Japan - Australia Biotechnology Cooperation
A round table discussion on the establishment of joint ventures in Biotechnology between Australia and Japan
Chairs: Keith Stanley & Ken-ichi Arai
Sponsored by the New South Wales Government |
|
|
|
|
|
|
| © 2007 Discovery Science and Biotechnology, Inc | Website by MTCi | Please send comments | |
|